- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04135066
Westlake Nutrition and Brain Health Study (WEBRAIN)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The gut-brain axis has been considered a possible cause of neurodegenerative diseases via various mechanisms, and diet/nutrition has been linked to both gut and brain health. However, majority of related evidence derived from animal models or human study of small scale.
In the WEBRAIN, we aim to investigate the relationship between diet, gut microbiome and brain structure and function in a large human cohort study via deep phenotyping the participants: 1) objective measurement of physical activity using accelerometers over 2 weeks; 2) continuous blood glucose monitoring over 2 weeks, with two standard test meal during the 2 weeks, and traditional diet assessment with FFQ and 24h recalls; 3) measurement of cognitive function and brain images with the Addenbrooke's Cognitive Examination-Revised (ACE-R) and brain MRI; and 4) measurement of gut microbiome using metagenome and 16S rRNA sequencing techniques.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ju-Sheng Zheng, PhD
- Phone Number: 86-0571-86915303
- Email: zhengjusheng@westlake.edu.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China, 510275
- Sun Yat-sen University
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310024
- Westlake University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Participants within the Guangzhou Nutrition and Health Study, without Alzheimer's disease, lived in Guangzhou, China, and aged 45 years or older;
Exclusion Criteria:
Participants with cancer and other serious medical disorders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Refined grain breakfast
white bread (100g) + milk powder (25g)
|
After wearing continuous glucose monitoring device (CGM) on baseline, participants will be provided with breakfast A on two consecutive days in a whoe 14-day monitoring period.
The appearance of breakfast A is pseudorandom.
Breakfast A contains white bread (100g) and milk powder (25g).
Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
Other Names:
|
Other: Whole grain breakfast
plain oats (70g) + milk powder (25g)
|
After wearing CGM on baseline, participants will be provided with breakfast B on two consecutive days in a whoe 14-day monitoring period.
The appearance of breakfast B is pseudorandom.
Breakfast B contains plain oats (70g) and milk powder (25g).
Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brain images
Time Frame: at enrollment
|
Brain structure and function was measured by brain magnetic resonance imaging (MRI)
|
at enrollment
|
Continuous blood glucose profile over 2 weeks
Time Frame: at enrollment
|
Glucose levels were measured by continuous glucose monitoring over 2 week
|
at enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cognitive scores
Time Frame: at enrollment
|
Cognitive function was measured by the Addenbrooke's Cognitive Examination-Revised (ACE-R).
The original 26 components were combined to produce five subscores, 100 in total.
The cutoff for dementia is 82-88/100.
|
at enrollment
|
incidence of Alzheimer's disease (AD)
Time Frame: 6 and 10 years after enrollment
|
New cases of AD will be diagnosed by neurological clinician according to the Chinese guideline for the diagnosis and treatment of Alzheimer's disease dementia(2020).
|
6 and 10 years after enrollment
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 20190901ZJS0010
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on Refine grain breakfast
-
Westlake UniversityCompleted
-
Westlake UniversityCompletedHealthy | Overweight and ObesityChina
-
Aventure ABGlucanova ABCompleted
-
USDA Beltsville Human Nutrition Research CenterCompleted
-
Purdue UniversityGrain Food FoundationRecruitingHigh Whole Grain and Low Sugar | Medium Whole Grain and Low Sugar | Low Whole Grain and Low Sugar | Low Whole Grain and High SugarUnited States
-
University of MinnesotaCompleted
-
University of CopenhagenTechnical University of DenmarkUnknownMetabolic Disease | Injury of Gastrointestinal TractDenmark
-
USDA Beltsville Human Nutrition Research CenterUnited States Department of Agriculture (USDA)Completed
-
University of FloridaGeneral MillsCompleted
-
University of Illinois at Urbana-ChampaignRecruitingCardiovascular Diseases | Dysbiosis | Gastrointestinal Dysfunction | Nutritional and Metabolic DiseasesUnited States